Home Cart Sign in  
Chemical Structure| 608512-97-6 Chemical Structure| 608512-97-6

Structure of PKR-IN-C16
CAS No.: 608512-97-6

Chemical Structure| 608512-97-6

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

PKR-IN-C16 is a specific protein kinase (PKR) inhibitor. It shows to effectively inhibit RNA-induced PKR autophosphorylation (IC50 = 210 nM) and rescue PKR-dependent translation block (IC50 = 100 nM).

Synonyms: PKR Inhibitor; imoxin; C16, PKR Inhibitor.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of PKR-IN-C16

CAS No. :608512-97-6
Formula : C13H8N4OS
M.W : 268.29
SMILES Code : O=C1NC2=C(C(SC=N3)=C3C=C2)C1=CC4=CNC=N4
Synonyms :
PKR Inhibitor; imoxin; C16, PKR Inhibitor.
MDL No. :MFCD28046009
InChI Key :VFBGXTUGODTSPK-BAQGIRSFSA-N
Pubchem ID :6490494

Safety of PKR-IN-C16

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
HeLa cells 0-96 μM 2.5 hours To evaluate the activation of GCN2 by the PKR inhibitor C16, results showed that C16 activated GCN2 between 0.19 to 1.5 μM and inhibited GCN2 at higher concentrations. Nat Commun. 2023 Sep 8;14(1):5535.
Retinal endothelial cells 2 µM To investigate whether PKR inhibition regulates the NLRP3 inflammasome pathway, results showed that PKR inhibition significantly reduced NLRP3, cleaved caspase 1, and IL-1β levels. J Inflamm Res. 2019 Jun 12;12:153-159.
Retinal endothelial cells 2 µM 16 hours To determine the optimal dose of C16 for inhibiting PKR phosphorylation, results showed that 2 µM C16 effectively reduced PKR phosphorylation. J Inflamm Res. 2019 Jun 12;12:153-159.
U-2 OS cells 1μM 48 hours C16 attenuates phosphorylation of p53 on Ser46 and Ser392 and prevents or attenuates upregulation of innate immunity genes. Cell Signal. 2020 May;69:109552.
A549 cells 1μM 48 hours C16 inhibits phosphorylation of p53 on Ser46 and Ser392 and prevents upregulation of innate immunity genes. Cell Signal. 2020 May;69:109552.
Huh7 cells 0, 500, 1000, 2000, 3000 nM 24 hours To evaluate the effect of C16 on HCC cell proliferation. C16 suppressed proliferation of HCC cells in a dose-dependent manner, with maximum effects seen at >2000 nM. Sci Rep. 2020 Mar 20;10(1):5133.
HT29 cells 100, 500, 1000 nM 24 hours C16 suppressed the proliferation of HT29 cells in a dose-dependent manner. Sci Rep. 2024 Apr 19;14(1):9029.
HCT116 cells 100, 500, 1000 nM 24 hours C16 suppressed the proliferation of HCT116 cells in a dose-dependent manner. Sci Rep. 2024 Apr 19;14(1):9029.

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice Tg26 transgenic mouse model Intraperitoneal injection 10 µg/kg body weight Three times weekly from 6 to 12 weeks of age PKR inhibition by compound C16 ameliorates the HIV-associated nephropathy (HIVAN) kidney phenotype in the Tg26 transgenic mouse model, with reversal of mitochondrial dysfunction. Elife. 2024 Aug 29;12:RP91260
Nude mice Xenograft model Intraperitoneal injection 300 μg/kg Once daily for 4 weeks To evaluate the effect of C16 on HCC tumor growth. C16 significantly suppressed tumor growth and decreased angiogenesis in HCC tissue. Sci Rep. 2020 Mar 20;10(1):5133.

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.73mL

0.75mL

0.37mL

18.64mL

3.73mL

1.86mL

37.27mL

7.45mL

3.73mL

References

 

Historical Records

Categories